Article Information
History
- March 30, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Luís Nunes1,11,
- Fuqiang Li2,3,4,11,
- Meizhen Wu2,3,4,11,
- Tian Luo2,3,4,11,
- Klara Hammarström1,
- Emma Lundin1,
- Ingrid Ljuslinder5,
- Artur Mezheyeuski1,
- Per-Henrik Edqvist1,
- Anna Löfgren-Burström6,
- Carl Zingmark6,
- Sofia Edin6,
- Chatarina Larsson1,
- Lucy Mathot1,
- Erik Osterman1,
- Emerik Osterlund1,
- Viktor Ljungström1,
- Inês Neves1,
- Nicole Yacoub1,
- Unnur Guðnadóttir1,
- Helgi Birgisson7,
- Malin Enblad7,
- Fredrik Ponten1,
- Richard Palmqvist6,
- Mathias Uhlén8,9,
- Kui Wu2,3,4,10,12,
- Bengt Glimelius1,12,
- Cong Lin2,3,4,12 and
- Tobias Sjöblom1,12,*
- 1Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
- 2BGI-Hangzhou, Hangzhou 310012, China
- 3BGI-Shenzhen, Shenzhen 518083, China
- 4Guangdong Provincial Key Laboratory of Human Disease Genomics, Shenzhen Key Laboratory of Genomics, BGI-Shenzhen, Shenzhen 518083, China
- 5Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden
- 6Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden
- 7Department of Surgical Sciences, Uppsala University, Akademiska sjukhuset, Uppsala, Sweden
- 8Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
- 9Science for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Stockholm, Sweden
- 10Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China
- ↵*To whom correspondence should be addressed at tobias.sjoblom{at}igp.uu.se
↵11 These authors contributed equally: Luís Nunes, Fuqiang Li, Meizhen Wu and Tian Luo
Posted March 30, 2023.
